Can-Fite BioPharma Ltd. (CANF)
NYSE: CANF · Pharmaceutical Preparations · Ramat Gan, IL · filing with the SEC since 2011
Who runs Can-Fite BioPharma Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Farbstein Motti
CEO, CFO and COO. First filing Mar 2026, latest Jun 8, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Farbstein Motti | CEO, CFO and COO | Mar 2026 | Jun 8, 2026 | none |
| Fishman Pnina | Chief Scientific Officer | Mar 2026 | Jun 8, 2026 | none |
| Fishman Sari | VP Business Development | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Tamir Ilan | director | Apr 2026 | Apr 23, 2026 | none |
| Regev Guy | director | Apr 2026 | Apr 6, 2026 | none |
| Bornstein Yoseph | director | Mar 2026 | Mar 18, 2026 | none |
| Sartani Abraham | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.